New survey highlights the impact of EGIDs on families

Imagine if food caused pain... nausea… reflux… was hard to swallow or even suddenly became stuck in your esophagus. That can be the reality for someone living with an eosinophilic gastrointestinal disorder (EGID).

During National EOS Awareness Week, 4-10 August, ausEE Inc. is putting the spotlight on EGIDs and the day-to-day impact living with them has on families.

It is estimated that one in two thousand Australians live with eosinophilic esophagitis (EoE) which is the most common type of EGID. People living with EGIDs often live with food restrictions which make it hard on physical, emotional and social levels.

A recent survey of more than a hundred people who live with or care for someone with an EGID highlighted the social impact of these inflammatory allergic conditions. 89% of survey respondents said they had difficulty going to a restaurant and 77% reported being anxious about attending social gatherings. A staggering 88% of people found it difficult to go to social occasions/parties/celebrations and sadly, 49% felt they had been left out of a social activity because of their EGID.

The ausEE Inc. survey also found that 90% felt that EGIDs impacted on their food budgets and 81% said that medicines and supplements for EGIDs also had a cost impact for them. 55% of respondents reported that having an EGID or caring for someone with an EGID also impacted on the number of hours they could work and this is significant considering the additional costs families face with food, medicines and supplements.

Whilst it was encouraging to see that 58% of respondents reported they had some support from family and friends, devastatingly, 34% said that they were largely managing on their own with 8% reporting that family and friends sometimes made it harder for them.

Sarah Gray, President of ausEE Inc., the National patient advocacy organisation for eosinophilic disorders said the survey results showed why it’s imperative for people living with an EGID to have good support networks in place and why it’s important to increase awareness through campaigns like National EOS Awareness Week which incorporates Top 8 Challenge Day on 8 August.

You can feel very isolated living with an EGID as it is a real challenge to live in a society that focuses so much on food."

Sarah Gray, President, ausEE Inc.

ausEE Inc. provides free support networks and additionally is a source of valuable evidence-based information and practical resources for people living with the chronic disorders.

On the Top 8 Challenge, Sarah says:

We are calling on Australians to spend one day experiencing what it can be like living with an EGID by taking our Top 8 Challenge which is our fundraising and community awareness creating initiative."

There is no cure for EGIDs and one of the common treatment options is an elimination diet which is tailored to the individual. Whilst some people with an EGID may be able to identify specific food(s) that trigger symptoms, unfortunately most cannot. Some doctors may suggest removing up to 8 common foods allergens (milk, egg, soy, wheat, peanut, tree nut, shellfish, fish) which is the idea behind our Top 8 Challenge.

To take the challenge, the most common allergenic foods are to be removed from your diet on Thursday 8 August and how many you wish to remove is completely up to you.

Sarah says:

You might choose to go only without milk or no wheat and egg or eliminate as many of the top 8 foods you can, up to removing all 8 common food allergens."

100% funds raised through the Top 8 Challenge go to ausEE’s Medical Research Fund which supports Australian medical research. To date ausEE has provided nearly $100k in medical research grants with the aim being to improve the diagnosis and treatment options for people living with EGIDs and ultimately in search of a cure.

Source:

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
Post a new comment
Post
You might also like... ×
Researchers successfully treat pain using nanoparticles to deliver a non-opioid medication